show help

Salomon H

Author page

This page provides a summary of the entries in Polbase associated with this author.

The publication history graph presents the number of publications in Polbase by this author over time.

The polymerase chart indicates which polymerases this author has published on.

Polbase automatically discovers many polymerase papers as they are published. Some relevant papers are not included because the algorithm is designed to reduce background. Please contribute to polbase by adding your missing DNA polymerase papers.

Help icons:

The show help symbol in the upper-right corner of the page links to this help text. The question mark icon is used everywhere to indicate that help is available.

Missing references?

Publications:

Title Authors Year Journal
Antiviral activity and resistance profile of phosphazid--a novel prodrug of AZT. Salomon H Nucleosides & nucleotides
Selection and characterization of human immunodeficiency virus type 1 variants resistant to the (+) and (-) enantiomers of 2'-deoxy-3'-oxa-4'-thio-5-fluorocytidine. Salomon H 2000 Antimicrobial agents and chemotherapy
Selection of resistance-conferring mutations in HIV-1 by the nucleoside reverse transcriptase inhibitors (+/-)dOTC and (+/-)dOTFC. Salomon H 2000 Antiviral chemistry & chemotherapy
Resistance to antiretroviral drugs in patients with primary HIV-1 infection. Investigators of the Quebec Primary Infection Study. Salomon H 2000 International journal of antimicrobial agents
Prevalence of HIV-1 resistant to antiretroviral drugs in 81 individuals newly infected by sexual contact or injecting drug use. Investigators of the Quebec Primary Infection Study. Salomon H 2000 AIDS (London, England)
In vitro selection and characterization of HIV-1 with reduced susceptibility to PMPA. Salomon H 1999 Antivir Ther
Selection and characterization of HIV-1 variants resistant to the (+) and (-) enantiomers of 2'-deoxy-3'-oxa-4'-thiocytidine (dOTC). Salomon H 1999 Antiviral therapy
Diminished HIV-1 sensitivity to stavudine in patients on prolonged therapy occurs only at low levels and cannot be attributed to any single amino acid substitution in reverse transcriptase. Salomon H 1998 Antiviral therapy
Mutations at codon 184 in simian immunodeficiency virus reverse transcriptase confer resistance to the (-) enantiomer of 2',3'-dideoxy-3'-thiacytidine. Salomon H 1997 Antimicrobial agents and chemotherapy
The nucleoside analog-resistant E89G mutant of human immunodeficiency virus type 1 reverse transcriptase displays a broader cross-resistance that extends to nonnucleoside inhibitors. Salomon H 1996 Antimicrobial agents and chemotherapy
Resistance to (-)-2',3'-dideoxy-3'-thiacytidine (3TC) in HIV-1 isolated from paediatric patients. Salomon H 1996 Antiviral therapy
Enhanced fidelity of 3TC-selected mutant HIV-1 reverse transcriptase. Salomon H 1996 Science (New York, N.Y.)
[Molecular basis and clinical significance of HIV-1 resistance to nucleoside compounds]. Salomon H 1995 Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie
Antiviral activity and protection of cells against human immunodeficiency virus type-1 using an antisense oligodeoxyribonucleotide phosphorothioate complementary to the 5'-LTR region of the viral genome. Salomon H 1995 Gene
K65R mutation of human immunodeficiency virus type 1 reverse transcriptase encodes cross-resistance to 9-(2-phosphonylmethoxyethyl)adenine. Salomon H 1995 Antimicrobial agents and chemotherapy
Development of HIV-1 resistance to (-)2'-deoxy-3'-thiacytidine in patients with AIDS or advanced AIDS-related complex. Salomon H 1995 AIDS (London, England)
Development and significance of nucleoside drug resistance in infection caused by the human immunodeficiency virus type 1. Salomon H 1994 Clinical and investigative medicine. Médecine clinique et experimentale
Comparison of cord blood and peripheral blood mononuclear cells as targets for viral isolation and drug sensitivity studies involving human immunodeficiency virus type 1. Salomon H 1994 Journal of clinical microbiology
Identification of a mutation at codon 65 in the IKKK motif of reverse transcriptase that encodes human immunodeficiency virus resistance to 2',3'-dideoxycytidine and 2',3'-dideoxy-3'-thiacytidine. Salomon H 1994 Antimicrobial agents and chemotherapy
HIV resistance to anti-viral drugs. Salomon H 1993 Brazilian journal of medical and biological research = Revista brasileira de pesquisas médicas e biológicas / Sociedade Brasileira de Biofísica ... [et al.]

Version:20241218

Using Polbase tables:

Sorting:

Tables may be sorted by clicking on any of the column titles. A second click reverses the sort order. <Ctrl> + click on the column titles to sort by more than one column (e.g. family then name).

Filtering:

It is also possible to filter the table by typing into the search box above the table. This will instantly hide lines from the table that do not contain your search text.